Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Arizona
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
University of Miami
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Liverpool
Fred Hutchinson Cancer Center
Hoffmann-La Roche
Hoffmann-La Roche
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Sunnybrook Health Sciences Centre
University of Nebraska
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University Hospital Southampton NHS Foundation Trust
Masonic Cancer Center, University of Minnesota
University of Nebraska
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
TCR2 Therapeutics
Genentech, Inc.
M.D. Anderson Cancer Center
Precision BioSciences, Inc.
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Thomas Jefferson University
University of Alabama at Birmingham
Weill Medical College of Cornell University
Hoffmann-La Roche
M.D. Anderson Cancer Center
Northwell Health
SCRI Development Innovations, LLC
Seagen Inc.
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
Stanford University
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Universität des Saarlandes